Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease

Archives of Neurology

Volumn 67, Issue 6, 2010, Pages 739-745

  Dutheil, Fabien ^a,b   Beaune, Philippe ^a,b,c   Tzourio, Christophe ^a,d   Loriot, Marie Anne ^a,b,c   Elbaz, Alexis ^a,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; ORGANOCHLORINE INSECTICIDE; ORGANOCHLORINE PESTICIDE; PESTICIDE;

AGED; AGRICULTURAL WORKER; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GARDENING; GENOTYPE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADOLESCENT; ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EXONS; FEMALE; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; PESTICIDES; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77953646529     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.101     Document Type: Article

References (43)

1. Klein C, Schlossmacher MG. The genetics of Parkinson disease: implications for neurological care. Nat Clin Pract Neurol. 2006;2(3):136-146. (Pubitemid 43307390)
2. Langston JW, Forno LS, Rebert CS, Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 1984;292(2):390-394.
3. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson's disease - is there a link? Environ Health Perspect. 2006;114(2):156-164.
4. Elbaz A, Clavel J, Rathouz PJ, et al. Professional exposure to pesticides and Parkinson's disease. Ann Neurol. 2009;66(4):494-504.
5. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989;86(2):695-698. (Pubitemid 19037807)
6. Bain LJ, LeBlanc GA. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol Appl Pharmacol. 1996;141 (1):288-298.
7. Sreeramulu K, Liu R, Sharom FJ. Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function. Biochim Biophys Acta. 2007; 1768(7):1750-1757.
8. Furuno T, Landi MT, Ceroni M, et al. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics. 2002;12(7):529-534. (Pubitemid 35177082)
9. Droździk M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics. 2003;13(5):259-263. (Pubitemid 36583992)
10. Lee CG, Tang K, Cheung YB, et al. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese. J Med Genet. 2004; 41(5):e60.
11. Tan EK, Chan DK, Ng PW, et al. Effect of MDR1 haplotype on risk of Parkinson disease. Arch Neurol. 2005;62(3):460-464.
12. Zschiedrich K, Konig IR, Bruggemann N, et al. MDR1 variants and risk of Parkinson disease: association with pesticide exposure? J Neurol. 2009;256(1): 115-120.
13. Westerlund M, Belin AC, Anvret A, et al. Association of a polymorphism in the ABCB1 gene with Parkinson's disease. Parkinsonism Relat Disord. 2009;15 (6):422-424.
14. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999; 52(6):1214-1220.
15. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol. 1996;144(3):207-213.
16. Elbaz A, Levecque C, Clavel J, et al. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol. 2004;55(3):430-434. (Pubitemid 38269597)
17. Tan EK, Drozdzik M, Bialecka M, et al. Analysis of MDR1 haplotypes in Parkinson's disease in a white population. Neurosci Lett. 2004;372(3):240-244.
18. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet. 1998; 352(9137):1344-1346. (Pubitemid 28510915)
19. Kelada SN, Checkoway H, Kardia SL, et al. 5′ and 3′ region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study. Hum Mol Genet. 2006;15(20):3055-3062.
20. Ritz BR, Manthripragada AD, Costello S, et al. Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect. 2009; 117(6):964-969.
21. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology. 1996;46(5):1275-1284. (Pubitemid 26159286)
22. Koldkjaer OG, Wermuth L, Bjerregaard P. Parkinson's disease among Inuit in Greenland: organochlorines as risk factors. Int J Circumpolar Health. 2004;63(suppl 2):366-368.
23. Hancock DB, Martin ER, Mayhew GM, et al. Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 2008;8(6):6.
24. Richardson JR, Shalat SL, Buckley B, et al. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009;66(7):870-875.
25. Petersen MS, Halling J, Bech S, et al. Impact of dietary exposure to food contaminants on the risk of Parkinson's disease. Neurotoxicology. 2008;29(4): 584-590.
26. Tebourbi O, Driss MR, Sakly M, Rhouma KB. Metabolism of DDT in different tissues of young rats. J Environ Sci Health B. 2006;41(2):167-176.
27. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A. 2000;59(4):229-234.
28. Kirby ML, Barlow RL, Bloomquist JR. Neurotoxicity of the organochlorine insecticide heptachlor to murine striatal dopaminergic pathways. Toxicol Sci. 2001; 61(1):100-106.
29. Kitazawa M, Anantharam V, Kanthasamy AG. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptotic cell death in dopaminergic cells. Free Radic Biol Med. 2001;31(11):1473-1485. (Pubitemid 33145318)
30. Miller GW, Erickson JD, Perez JT, et al. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp Neurol. 1999; 156(1):138-148.
31. Miller GW, Kirby ML, Levey AI, Bloomquist JR. Heptachlor alters expression and function of dopamine transporters. Neurotoxicology. 1999;20(4):631-637.
32. Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology. 2005;26(4):701-719. (Pubitemid 41175903)
33. Hatcher JM, Richardson JR, Guillot TS, et al. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol. 2007; 204(2):619-630.
34. Phang JM, Poore CM, Lopaczynska J, Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res. 1993;53(24):5977-5981. (Pubitemid 24006169)
35. Yeh GC, Lopaczynska J, Poore CM, Phang JM. A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. Cancer Res. 1992;52(23):6692-6695.
36. Shabbir A, DiStasio S, Zhao J, Cardozo CP, Wolff MS, Caplan AJ. Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on pglycoprotein activity and expression. Toxicol Appl Pharmacol. 2005;203(2): 91-98.
37. Schinkel AH, Smit JJ, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77(4):491-502.
38. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315(5811):525- 528.
39. Salama NN, Yang Z, Bui T, Ho RJ. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J Pharm Sci. 2006;95(10):2293-2308.
40. Yamauchi A, Ieiri I, Kataoka Y, et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation. 2002;74(4):571-572.
41. Allison PD. Imputation of categorical variables with Proc MI. In: SUGI 30 Proceedings; April 10-13, 2005; Philadelphia, PA. Paper 113-30.
42. Lecoeur S, Videmann B, Mazallon M. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Toxicol Lett. 2006; 161(3):200-209.
43. Agarwala S, Chen W, Cook TJ. Effect of chlorpyrifos on efflux transporter gene expression and function in Caco-2 cells. Toxicol In Vitro. 2004;18(4):403-409.